FDA Inspection 884684 — Indiana Blood Center

Indiana Blood Center — FEI 3000204211

The FDA completed an inspection of Indiana Blood Center on Jun 25, 2014 in Columbus, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 25, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Columbus, IN (United States)